Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Vissing

Showing results (21-30 of 416) with videos related to

Pageof 42
Sort By:
Archives of Neurology|September 12, 2002
Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanismsRonald G Haller, John Vissing
Neurology|October 25, 2006
Treating MNGIE: is reducing blood nucleosides the first cure for a mitochondrial disorder?Patrick F Chinnery, John Vissing
Journal of Neuromuscular Diseases|August 2, 2021
Habitual Physical Activity in Patients with Myasthenia Gravis Assessed by Accelerometry and QuestionnaireLinda Kahr Andersen, John Vissing
Journal of Neuropathology and Experimental Neurology|November 18, 2015
A New Mouse Model of Limb-Girdle Muscular Dystrophy Type 2I Homozygous for the Common L276I Mutation Mimicking the Mild Phenotype in HumansThomas O Krag, John Vissing
Neurology|January 14, 2004
No spontaneous second wind in muscle phosphofructokinase deficiencyRonald G Haller, John Vissing
Muscle & Nerve|May 25, 2023
Diagnosis and management of metabolic myopathiesSalman F Bhai, John Vissing
Neuromuscular Disorders : NMD|November 28, 2012
Mechanisms of exertional fatigue in muscle glycogenosesJohn Vissing, Ronald G Haller
Current Treatment Options in Neurology|September 22, 2017
Treatment Opportunities in Patients With Metabolic MyopathiesMette Cathrine Ørngreen, John Vissing
Current Opinion in Neurology|July 25, 2017
Update on new muscle glycogenosisPascal Laforêt, Edoardo Malfatti, John Vissing
The Journal of Clinical Endocrinology and Metabolism|July 25, 2014
Insulin resistance and increased muscle cytokine levels in patients with mitochondrial myopathyNana Rue, John Vissing, Henrik Galbo
Pageof 42

Showing results (21-30 of 416) with videos related to

Sort By:
Pageof 42
Archives of Neurology|September 12, 2002
Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanismsRonald G Haller, John Vissing
Neurology|October 25, 2006
Treating MNGIE: is reducing blood nucleosides the first cure for a mitochondrial disorder?Patrick F Chinnery, John Vissing
Journal of Neuromuscular Diseases|August 2, 2021
Habitual Physical Activity in Patients with Myasthenia Gravis Assessed by Accelerometry and QuestionnaireLinda Kahr Andersen, John Vissing
Journal of Neuropathology and Experimental Neurology|November 18, 2015
A New Mouse Model of Limb-Girdle Muscular Dystrophy Type 2I Homozygous for the Common L276I Mutation Mimicking the Mild Phenotype in HumansThomas O Krag, John Vissing
Neurology|January 14, 2004
No spontaneous second wind in muscle phosphofructokinase deficiencyRonald G Haller, John Vissing
Muscle & Nerve|May 25, 2023
Diagnosis and management of metabolic myopathiesSalman F Bhai, John Vissing
Neuromuscular Disorders : NMD|November 28, 2012
Mechanisms of exertional fatigue in muscle glycogenosesJohn Vissing, Ronald G Haller
Current Treatment Options in Neurology|September 22, 2017
Treatment Opportunities in Patients With Metabolic MyopathiesMette Cathrine Ørngreen, John Vissing
Current Opinion in Neurology|July 25, 2017
Update on new muscle glycogenosisPascal Laforêt, Edoardo Malfatti, John Vissing
The Journal of Clinical Endocrinology and Metabolism|July 25, 2014
Insulin resistance and increased muscle cytokine levels in patients with mitochondrial myopathyNana Rue, John Vissing, Henrik Galbo
Pageof 42